-
Innovation Ranking
NewInnovation Ranking – Hunan Er-Kang Pharmaceutical Co Ltd
Hunan Er-Kang Pharmaceutical Co Ltd (Hunan Er-Kang) is a provider of the development, production and sale of pharmaceutical drugs and active pharmaceutical ingredients. The company's products include aminocaproic acid injection, aminophylline injection, sulfoethylamine injection, sulfadiazine sodium injection, chlorpheniramine maleate injection, and tobramycin sulfate injection, vitamin B6 Injection, chlorpheniramine maleate tablets, ganmaoling granules, aminojia huangmin capsules, Sulfenbenicillin Sodium for Injection and compound licorice tablets among others. Hunan Er-Kang is headquartered in Changsha City, Hunan, China.
-
Product Insights
NewNet Present Value Model: PainReform Ltd’s Ropivacaine ER
Empower your strategies with our Net Present Value Model: PainReform Ltd's Ropivacaine ER report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewNet Present Value Model: Teva Pharmaceutical Industries Ltd’s Olanzapine ER
Empower your strategies with our Net Present Value Model: Teva Pharmaceutical Industries Ltd's Olanzapine ER report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Levetiracetam ER in Psychosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Levetiracetam ER in Psychosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Levetiracetam ER in Psychosis Drug Details: Levetiracetam ER (AGB-101) is under development...
-
Product Insights
NewNet Present Value Model: Trevi Therapeutics Inc’s Nalbuphine Hydrochloride ER
Empower your strategies with our Net Present Value Model: Trevi Therapeutics Inc's Nalbuphine Hydrochloride ER report and make more profitable business decisions.Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Acetaminophen ER in Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Acetaminophen ER in Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acetaminophen ER in Pain Drug Details: Acetaminophen extended release is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Rosuvastatin ER in Dyslipidemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Rosuvastatin ER in Dyslipidemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rosuvastatin ER in Dyslipidemia Drug Details: Rosuvastatin extended-release capsule (LYN-047) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Upadacitinib ER in Vitiligo
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Upadacitinib ER in Vitiligo report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Upadacitinib ER in Vitiligo Drug Details: Upadacitinib (Rinvoq, Rim-Voq) is an...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Minocycline Hydrochloride ER in Rosacea
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Minocycline Hydrochloride ER in Rosacea report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Minocycline Hydrochloride ER in Rosacea Drug Details: Minocycline hydrochloride is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Upadacitinib ER in Alopecia Areata
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Upadacitinib ER in Alopecia Areata report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Upadacitinib ER in Alopecia Areata Drug Details: Upadacitinib (Rinvoq, Rim-Voq)...